Compare Stocks

Date Range: 

 AlectorReplimune GroupC4 TherapeuticsOcugenTranslate Bio
SymbolNASDAQ:ALECNASDAQ:REPLNASDAQ:CCCCNASDAQ:OCGNNASDAQ:TBIO
Price Information
Current Price$16.35$35.84$34.28$9.19$19.43
52 Week RangeBuyBuyBuyBuyBuy
MarketRank™
Overall Score1.31.51.41.01.6
Analysis Score3.53.53.51.34.3
Community Score2.42.43.13.31.8
Dividend Score0.00.00.00.00.0
Ownership Score0.81.70.00.01.7
Earnings & Valuation Score0.00.00.60.60.0
Analyst Ratings
Consensus RecommendationBuyBuyBuyBuyBuy
Consensus Price Target$34.40$56.00$44.50$6.55$25.70
% Upside from Price Target110.40% upside56.25% upside29.81% upside-28.69% downside32.27% upside
Trade Information
Market Cap$1.30 billion$1.67 billion$1.48 billion$1.73 billion$1.46 billion
Beta1.082.63N/A3.560.96
Average Volume624,227384,547275,70674,082,6801,177,359
Sales & Book Value
Annual Revenue$21.22 millionN/AN/AN/A$7.80 million
Price / Sales61.46N/AN/AN/A187.40
CashflowN/AN/AN/AN/AN/A
Price / CashN/AN/AN/AN/AN/A
Book Value$2.83 per share$5.01 per shareN/A$0.21 per share$2.56 per share
Price / Book5.78N/AN/AN/A7.59
Profitability
Net Income$-105,390,000.00$-52,630,000.00N/A$-20,240,000.00$-113,290,000.00
EPS($1.71)($1.54)N/A($1.48)($1.84)
Trailing P/E RatioN/AN/A0.00N/AN/A
Forward P/E RatioN/AN/AN/AN/AN/A
P/E GrowthN/AN/AN/AN/AN/A
Net Margins-757.78%N/AN/AN/A-70.38%
Return on Equity (ROE)-53.86%-30.23%N/A-47.72%-27.54%
Return on Assets (ROA)-31.44%-24.66%N/A-30.78%-12.82%
Dividend
Annual PayoutN/AN/AN/AN/AN/A
Dividend YieldN/AN/AN/AN/AN/A
Three-Year Dividend GrowthN/AN/AN/AN/AN/A
Payout RatioN/AN/AN/AN/AN/A
Years of Consecutive Dividend GrowthN/AN/AN/AN/AN/A
Debt
Debt-to-Equity RatioN/A0.13%N/A0.13%N/A
Current Ratio6.61%19.47%5.22%4.78%5.73%
Quick Ratio6.61%19.47%5.22%4.78%5.73%
Ownership Information
Institutional Ownership Percentage61.50%55.79%N/A8.53%92.90%
Insider Ownership Percentage13.90%50.90%N/A3.54%12.30%
Miscellaneous
Employees1711229915122
Shares Outstanding79.76 million46.49 million43.19 million188.17 million75.23 million
Next Earnings Date8/10/2021 (Estimated)6/2/2021 (Estimated)6/10/2021 (Estimated)8/13/2021 (Estimated)8/5/2021 (Estimated)
OptionableNot OptionableNot OptionableNot OptionableNot OptionableNot Optionable
SourceHeadline
Results: Translate Bio, Inc. Exceeded Expectations And The Consensus Has Updated Its EstimatesResults: Translate Bio, Inc. Exceeded Expectations And The Consensus Has Updated Its Estimates
finance.yahoo.com - May 9 at 1:41 PM
Evercore ISI Stick to Their Hold Rating for Translate Bio IncEvercore ISI Stick to Their Hold Rating for Translate Bio Inc
investing.com - May 9 at 8:41 AM
Translate Bio Inc. [TBIO] Stock trading around $18.74 per share: What’s Next?Translate Bio Inc. [TBIO] Stock trading around $18.74 per share: What’s Next?
dbtnews.com - May 7 at 10:11 AM
Translate Bio, Inc. (TBIO) Reports Q1 Loss, Misses Revenue EstimatesTranslate Bio, Inc. (TBIO) Reports Q1 Loss, Misses Revenue Estimates
finance.yahoo.com - May 6 at 11:06 PM
TBIO Crosses Below Key Moving Average LevelTBIO Crosses Below Key Moving Average Level
nasdaq.com - May 6 at 6:06 PM
Translate Bio Announces First Quarter 2021 Financial Results and Provides Corporate UpdateTranslate Bio Announces First Quarter 2021 Financial Results and Provides Corporate Update
finance.yahoo.com - May 6 at 6:06 PM
Translate Bio (NASDAQ:TBIO) Trading Down 13.1%Translate Bio (NASDAQ:TBIO) Trading Down 13.1%
americanbankingnews.com - May 6 at 1:54 PM
Translate Bio, Inc. (NASDAQ:TBIO): How Much Is It Worth And What Should Investors Do?Translate Bio, Inc. (NASDAQ:TBIO): How Much Is It Worth And What Should Investors Do?
marketingsentinel.com - May 1 at 3:07 PM
Will Translate Bio, Inc. (TBIO) Report Negative Q1 Earnings? What You Should KnowWill Translate Bio, Inc. (TBIO) Report Negative Q1 Earnings? What You Should Know
finance.yahoo.com - April 29 at 8:32 PM
Translate Bio to Present at the 7th Annual Truist Securities Life Sciences SummitTranslate Bio to Present at the 7th Annual Truist Securities Life Sciences Summit
finance.yahoo.com - April 28 at 8:27 AM
Translate Bio (NASDAQ:TBIO)  Shares Down 2.5% Translate Bio (NASDAQ:TBIO) Shares Down 2.5%
americanbankingnews.com - April 23 at 11:58 AM
Translate Bio (NASDAQ:TBIO) Shares Up 7.5%Translate Bio (NASDAQ:TBIO) Shares Up 7.5%
americanbankingnews.com - April 22 at 1:58 PM
Translate Bio, Inc. (NASDAQ:TBIO) Stock Could Reward Investors With a 41.56% GainTranslate Bio, Inc. (NASDAQ:TBIO) Stock Could Reward Investors With a 41.56% Gain
marketingsentinel.com - April 21 at 12:16 PM
Translate Bio Announces Publication of Preclinical Results of COVID-19 mRNA Vaccine Candidate ...Translate Bio Announces Publication of Preclinical Results of COVID-19 mRNA Vaccine Candidate ...
apnews.com - April 20 at 6:12 AM
Translate Bio Announces Publication of Preclinical Results of COVID-19 mRNA Vaccine Candidate MRT5500 in npj VaccinesTranslate Bio Announces Publication of Preclinical Results of COVID-19 mRNA Vaccine Candidate MRT5500 in npj Vaccines
sg.finance.yahoo.com - April 19 at 7:39 AM
First Week of June 18th Options Trading For Translate Bio (TBIO)First Week of June 18th Options Trading For Translate Bio (TBIO)
nasdaq.com - April 16 at 8:12 PM
Translate Bio (NASDAQ:TBIO) Trading 5% Higher Translate Bio (NASDAQ:TBIO) Trading 5% Higher
americanbankingnews.com - April 15 at 11:37 AM
Translate Bio Inc (TBIO)Translate Bio Inc (TBIO)
investing.com - April 15 at 6:45 AM
Wall Street’s Take On Translate Bio, Inc. (NASDAQ:TBIO) StockWall Street’s Take On Translate Bio, Inc. (NASDAQ:TBIO) Stock
stocksregister.com - April 12 at 12:40 PM
Translate Bio Inc. [TBIO] Stock trading around $17.26 per share: What’s Next?Translate Bio Inc. [TBIO] Stock trading around $17.26 per share: What’s Next?
dbtnews.com - April 12 at 7:40 AM
Translate Bio, Inc. (TBIO) investors to reap big returns againTranslate Bio, Inc. (TBIO) investors to reap big returns again
marketingsentinel.com - March 25 at 1:24 PM
Translate Bio Appoints Dr. Rand Sutherland as PresidentTranslate Bio Appoints Dr. Rand Sutherland as President
finance.yahoo.com - March 22 at 8:47 AM
TBIO Stock Price Fell Over 30% Intraday: Why It HappenedTBIO Stock Price Fell Over 30% Intraday: Why It Happened
pulse2.com - March 19 at 9:37 AM
Why Translate Bio Shares Are Tanking TodayWhy Translate Bio Shares Are Tanking Today
finance.yahoo.com - March 18 at 2:24 PM
Translate (TBIO) Down on Unsatisfactory CF Drug Study ResultsTranslate (TBIO) Down on Unsatisfactory CF Drug Study Results
msn.com - March 18 at 9:24 AM
DateCompanyBrokerageAction
4/26/2021AlectorMorgan StanleyBoost Price Target
1/15/2021AlectorBank of AmericaInitiated Coverage
11/11/2020AlectorSmith Barney CitigroupLower Price Target
7/29/2020AlectorBarclaysLower Price Target
6/24/2020AlectorHC WainwrightInitiated Coverage
4/28/2020AlectorThe Goldman Sachs GroupInitiated Coverage
3/5/2020AlectorCitigroupInitiated Coverage
2/18/2020AlectorStifel NicolausInitiated Coverage
12/16/2019AlectorCowenReiterated Rating
11/27/2019AlectorBTIG ResearchInitiated Coverage
3/4/2019AlectorSVB LeerinkInitiated Coverage
11/6/2020Replimune GroupBMO Capital MarketsBoost Price Target
11/2/2020Replimune GroupJefferies Financial GroupInitiated Coverage
10/14/2020Replimune GroupRoth CapitalBoost Price Target
10/14/2020Replimune GroupChardan CapitalBoost Price Target
6/3/2020Replimune GroupWedbushReiterated Rating
10/28/2020C4 TherapeuticsUBS GroupInitiated Coverage
5/7/2021OcugenCantor FitzgeraldDowngrade
3/24/2021Translate BioTruist SecuritiesReiterated Rating
3/24/2021Translate BioEvercore ISIReiterated Rating
3/19/2021Translate BioWilliam BlairReiterated Rating
6/26/2020Translate BioSunTrust BanksInitiated Coverage
(Data available from 5/9/2018 forward. View 10+ years of historical ratings with our analyst ratings screener.)
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security. Learn more.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.